Interleukin-1 Receptor Antagonist and Insulin Sensitivity

NCT00928876 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Insulin Resistance

Interventions

DRUG: Anakinra (Kineret)
DRUG: Placebo

Sponsor

Radboud University Medical Center